Potential role of hematopoietic pre-B-cell leukemia transcription factor-interacting protein in oral carcinogenesis

Journal of Oral Pathology and Medicine

Volumn 44, Issue 2, 2015, Pages 115-125

  Okada, Seiji ^a   Irié, Tarou ^a   Tanaka, Junichi ^a   Yasuhara, Rika ^a   Yamamoto, Gou ^a   Isobe, Tomohide ^a   Hokazono, Chie ^a   Tachikawa, Tetsuhiko ^a   Kohno, Yohko ^a   Mishima, Kenji ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Carcinogenesis; Differentiation; Epithelial precursor lesion; Hematopoietic pre B cell leukemia transcription factor interacting protein; Oral squamous cell carcinoma

Indexed keywords

CALCIUM; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INVOLUCRIN; KI 67 ANTIGEN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR PBX1; PBXIP1 PROTEIN, HUMAN; PROTEIN PRECURSOR; TRANSCRIPTION FACTOR;

ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION ASSAY; EXTRACELLULAR CALCIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING; ADULT; AGED; CARCINOMA IN SITU; CELL CULTURE TECHNIQUE; CELL MOTION; CELL PROLIFERATION; FEMALE; GENE SILENCING; GENETICS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; PHYSIOLOGY; PRECANCER; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ADULT; AGED; CALCIUM; CARCINOGENESIS; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE SILENCING; HUMANS; KERATINOCYTES; KI-67 ANTIGEN; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; PROTEIN PRECURSORS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 84921439342     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12210     Document Type: Article

References (43)

1. Abramovich C, Shen WF, Pineault N, et al. Functional cloning and characterization of a novel nonhomeodomain protein that inhibits the binding of PBX1-HOX complexes to DNA. J Biol Chem 2000; 275: 26172-7.
2. Gehring WJ, Muller M, Affolter M, et al. The structure of the homeodomain and its functional implications. Trends Genet 1990; 6: 323-9.
3. Abramovich C, Chavez EA, Lansdorp PM, et al. Functional characterization of multiple domains involved in the subcellular localization of the hematopoietic Pbx interacting protein (HPIP). Oncogene 2002; 21: 6766-71.
4. Plowright L, Harrington KJ, Pandha HS, et al. HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). Br J Cancer 2009; 100: 470-5.
5. Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer 2010; 10: 361-71.
6. Morgan R, Boxall A, Harrington KJ, et al. Targeting the HOX/PBX dimer in breast cancer. Breast Cancer Res Treat 2012; 136: 389-98.
7. De Souza Setubal Destro MF, Bitu CC, Zecchin KG, et al. Overexpression of HOXB7 homeobox gene in oral cancer induces cellular proliferation and is associated with poor prognosis. Int J Oncol 2010; 36: 141-9.
8. Bitu CC, Destro MF, Carrera M, et al. HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis. BMC cancer 2012; 12: 146.
9. Hassan NM, Hamada J, Murai T, et al. Aberrant expression of HOX genes in oral dysplasia and squamous cell carcinoma tissues. Oncol Res 2006; 16: 217-24.
10. Ramberg H, Alshbib A, Berge V, et al. Regulation of PBX3 expression by androgen and Let-7d in prostate cancer. Mol Cancer 2011; 10: 50.
11. Qiu Y, Song B, Zhao G, et al. Expression level of Pre B cell leukemia homeobox 2 correlates with poor prognosis of gastric adenocarcinoma and esophageal squamous cell carcinoma. Int J Oncol 2010; 36: 651-63.
12. Xu X, Jiang C, Wang S, et al. HPIP is upregulated in liver cancer and promotes hepatoma cell proliferation via activation of G2/M transition. IUBMB Life 2013; 65: 873-82.
13. Manavathi B, Acconcia F, Rayala SK, et al. An inherent role of microtubule network in the action of nuclear receptor. Proc Natl Acad Sci USA 2006; 103: 15981-6.
14. Mikami T, Cheng J, Maruyama S, et al. Emergence of keratin 17 vs. loss of keratin 13: their reciprocal immunohistochemical profiles in oral carcinoma in situ. Oral Oncol 2011; 47: 497-503.
15. Molinolo AA, Hewitt SM, Amornphimoltham P, et al. Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative. Clin Cancer Res 2007; 13: 4964-73.
16. Patel H, Younis RH, Ord RA, et al. Differential expression of organic cation transporter OCT-3 in oral premalignant and malignant lesions: potential implications in the antineoplastic effects of metformin. J Oral Pathol Med 2013; 42: 250-6.
17. Mitra A, Raychaudhuri SK, Raychaudhuri SP. IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade. Cytokine 2012; 60: 38-42.
18. Rubin AL, Rice RH. Differential regulation by retinoic acid and calcium of transglutaminases in cultured neoplastic and normal human keratinocytes. Cancer Res 1986; 46: 2356-61.
19. Berglund L, Bjorling E, Oksvold P, et al. A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol Cell Proteomics 2008; 7: 2019-27.
20. Gale N, Pilch BZ, Sidransky D, et al. Epithelial precursor lesions. In: Barnes L, Eveson JW, Reichart P, Sidransky D. ed. World health organization classification of tumours pathology and genetics of head and neck tumours. Lyon: IARC Press, 2005; 177-9.
21. Micallef L, Belaubre F, Pinon A, et al. Effects of extracellular calcium on the growth-differentiation switch in immortalized keratinocyte HaCaT cells compared with normal human keratinocytes. Exp Dermatol 2009; 18: 143-51.
22. Nishi K, Inoue H, Schnier JB, et al. Cyclin D1 downregulation is important for permanent cell cycle exit and initiation of differentiation induced by anchorage-deprivation in human keratinocytes. J Cell Biochem 2009; 106: 63-72.
23. Denning MF, Guy SG, Ellerbroek SM, et al. The expression of desmoglein isoforms in cultured human keratinocytes is regulated by calcium, serum, and protein kinase C. Exp Cell Res 1998; 239: 50-9.
24. Matsui MS, Chew SL, Deleo VA. Protein kinase C in normal human epidermal keratinocytes during proliferation and calcium-induced differentiation. J Invest Dermatol 1992; 99: 565-71.
25. Aragao AZ, Belloni M, Simabuco FM, et al. Novel processed form of syndecan-1 shed from SCC-9 cells plays a role in cell migration. PLoS ONE 2012; 7: e43521.
26. Umegaki N, Tamai K, Nakano H, et al. Differential regulation of karyopherin alpha 2 expression by TGF-beta1 and IFN-gamma in normal human epidermal keratinocytes: evident contribution of KPNA2 for nuclear translocation of IRF-1. J Invest Dermatol 2007; 127: 1456-64.
27. Manavathi B, Lo D, Bugide S, et al. Functional regulation of pre-B-cell leukemia homeobox interacting protein 1 (PBXIP1/HPIP) in erythroid differentiation. J Biol Chem 2012; 287: 5600-14.
28. Wu HT, Ko SY, Fong JH, et al. Expression of phosphorylated Akt in oral carcinogenesis and its induction by nicotine and alkaline stimulation. J Oral Pathol Med 2009; 38: 206-13.
29. Hong KO, Kim JH, Hong JS, et al. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells. J Exp Clin Cancer Res 2009; 28: 28.
30. Kupferman ME, Jiffar T, El-Naggar A, et al. TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma. Oncogene 2010; 29: 2047-59.
31. Tseng YH, Chang CS, Liu TY, et al. Areca nut extract treatment down-regulates involucrin in normal human oral keratinocyte through P13K/AKT activation. Oral Oncol 2007; 43: 670-9.
32. Tseng YH, Yang CC, Lin SC, et al. Areca nut extract upregulates vimentin by activating PI3K/AKT signaling in oral carcinoma. J Oral Pathol Med 2011; 40: 160-6.
33. Imai K, Kumagai S, Nakagawa K, et al. Immunolocalization of desmoglein and intermediate filaments in human oral squamous cell carcinomas. Head Neck 1995; 17: 204-12.
34. Xu X, Fan Z, Kang L, et al. Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J Clin Invest 2013; 123: 630-45.
35. Wang X, Yang Z, Zhang H, et al. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT. Biochim Biophys Acta 2008; 1783: 1220-8.
36. Yamatoji M, Kasamatsu A, Yamano Y, et al. State of homeobox A10 expression as a putative prognostic marker for oral squamous cell carcinoma. Oncol Rep 2010; 23: 61-7.
37. Cui XP, Qin CK, Zhang ZH, et al. HOXA10 promotes cell invasion and MMP-3 expression via TGFbeta2-Mediated activation of the p38 MAPK pathway in pancreatic cancer cells. Dig Dis Sci 2014; 59: 1442-51.
38. Li B, Jin H, Yu Y, et al. HOXA10 is overexpressed in human ovarian clear cell adenocarcinoma and correlates with poor survival. Int J Gynecol Cancer 2009; 19: 1347-52.
39. Watanabe S, Sato K, Okazaki Y, et al. Activation of PI3K-AKT pathway in oral epithelial dysplasia and early cancer of tongue. Bull Tokyo Dent Coll 2009; 50: 125-33.
40. Kaur J, Sawhney M, Dattagupta S, et al. Clinical significance of altered expression of beta-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression. PLoS ONE 2013; 8: e67361.
41. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000; 182: 311-22.
42. Rubio CA. Further studies on the arrest of cell proliferation in tumor cells at the invading front of colonic adenocarcinoma. J Gastroenterol Hepatol 2007; 22: 1877-81.
43. Rubio CA. Arrest of cell proliferation in budding tumor cells ahead of the invading edge of colonic carcinomas. A preliminary report. Anticancer Res 2008; 28: 2417-20.